Cargando…

Long-term results of intensity-modulated radiotherapy with three dose-fractionation regimens for localized prostate cancer

We evaluated long-term outcomes of three protocols of intensity-modulated radiation therapy (IMRT) for localized prostate cancer. Between 2005 and 2014, 348 patients were treated with 5-field IMRT. The first 74 patients were treated with a daily fraction of 2.0 Gy to 74 Gy (low-risk prostate cancer)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takemoto, Shinya, Shibamoto, Yuta, Sugie, Chikao, Manabe, Yoshihiko, Yanagi, Takeshi, Iwata, Hiromitsu, Murai, Taro, Ishikura, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Regular Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430249/ https://www.ncbi.nlm.nih.gov/pubmed/30566649 http://dx.doi.org/10.1093/jrr/rry089

Ejemplares similares

Comparison of intensity-modulated radiotherapy with the 5-field technique, helical tomotherapy and volumetric modulated arc therapy for localized prostate cancer
por: Kita, Nozomi, et al.
Publicado: (2022)

Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer
por: Manabe, Yoshihiko, et al.
Publicado: (2014)

Definitive chemoradiotherapy for squamous cell carcinoma of the esophagus: outcomes for borderline-resectable disease
por: Ishikura, Satoshi, et al.
Publicado: (2020)

Helical and Static-port Tomotherapy Using the Newly-developed Dynamic Jaws Technology for Lung Cancer
por: Manabe, Yoshihiko, et al.
Publicado: (2015)

Changes in pulmonary function and their correlation with dose–volume parameters in patients undergoing stereotactic body radiotherapy for lung cancer
por: Takemoto, Shinya, et al.
Publicado: (2021)

Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study
por: Miyakawa, Akifumi, et al.
Publicado: (2017)

Comparison of multileaf collimator and conventional circular collimator systems in Cyberknife stereotactic radiotherapy
por: Murai, Taro, et al.
Publicado: (2017)

Efficacy of stereotactic radiotherapy for brain metastases using dynamic jaws technology in the helical tomotherapy system
por: Murai, Taro, et al.
Publicado: (2016)

Efficacy of the Dynamic Jaw Mode in Helical Tomotherapy With Static Ports for Breast Cancer
por: Sugie, Chikao, et al.
Publicado: (2015)

Whole-pelvic radiotherapy with spot-scanning proton beams for uterine cervical cancer: a planning study
por: Hashimoto, Shingo, et al.
Publicado: (2016)

Intensity-modulated radiation therapy using static ports of tomotherapy (TomoDirect): comparison with the TomoHelical mode
por: Murai, Taro, et al.
Publicado: (2013)

Intensity‐modulated radiation therapy for multiple targets with tomotherapy using multiple sets of static ports from different angles
por: Manabe, Yoshihiko, et al.
Publicado: (2020)

Effects of a combined treatment regimen consisting of Hsp90 inhibitor DS-2248 and radiation in vitro and in a tumor mouse model
por: Kondo, Takuhito, et al.
Publicado: (2021)

Biological Effects of Continuous Low-Dose-Rate Irradiation in Silkworms and Mice: Growth Promotion and Tumor Transplantability
por: Nakashima, Masahiro, et al.
Publicado: (2018)

Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size
por: Baba, Fumiya, et al.
Publicado: (2010)

CyberKnife Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy As First-line Treatments for Imaging-diagnosed Intracranial Meningiomas
por: MANABE, Yoshihiko, et al.
Publicado: (2017)

Biological effects of prostaglandin E2-EP4 antagonist (AAT-008) in murine colon cancer in vivo: enhancement of immune response to radiotherapy and potential as a radiosensitizer
por: Manabe, Yoshihiko, et al.
Publicado: (2023)

The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
por: Shibamoto, Yuta, et al.
Publicado: (2020)

Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016)

Treatment and prognosis of patients with late rectal bleeding after intensity-modulated radiation therapy for prostate cancer
por: Takemoto, Shinya, et al.
Publicado: (2012)

Applicability of the linear–quadratic model to single and fractionated radiotherapy schedules: an experimental study
por: Miyakawa, Akifumi, et al.
Publicado: (2014)

Efficacy of herbal medicine TJ-14 for acute radiation-induced enteritis: a multi-institutional prospective Phase II trial
por: Murai, Taro, et al.
Publicado: (2019)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
por: Murai, Taro, et al.
Publicado: (2012)

Helical tomotherapy for chemo‐refractory multiple liver metastases
por: Takaoka, Taiki, et al.
Publicado: (2019)

Immune-maximizing (IMAX) therapy for cancer: Combination of dendritic cell vaccine and intensity-modulated radiation
por: SHIBAMOTO, YUTA, et al.
Publicado: (2013)

Dose–volume histogram comparison between static 5-field IMRT with 18-MV X-rays and helical tomotherapy with 6-MV X-rays
por: Hayashi, Akihiro, et al.
Publicado: (2015)

Impact of advanced radiotherapy techniques and dose intensification on toxicity of salvage radiotherapy after radical prostatectomy
por: Tomita, Natsuo, et al.
Publicado: (2020)

Biological effects of hydrogen peroxide administered intratumorally with or without irradiation in murine tumors
por: Takaoka, Taiki, et al.
Publicado: (2017)

Local radiotherapy for pleural dissemination of thymic tumors after initial treatment
por: Okazaki, Dai, et al.
Publicado: (2021)

Helical tomotherapy for asymptomatic chemotherapy-refractory or -unfit multiple (3 or more) metastases
por: Yamada, Yuki, et al.
Publicado: (2022)

Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy
por: Tatekawa, Kotoha, et al.
Publicado: (2014)

Changes in the Proliferation Rate, Clonogenicity, and Radiosensitivity of Cultured Cells During and After Continuous Low-Dose-Rate Irradiation
por: Wang, Zhen, et al.
Publicado: (2019)

Definitive radiotherapy with stereotactic or IMRT boost with or without radiosensitization strategy for operable breast cancer patients who refuse surgery
por: Shibamoto, Yuta, et al.
Publicado: (2022)

Stereotactic body radiotherapy using the forward-planned static-port tomotherapy for lung cancer: a novel planning technique with the newly-developed mode
por: Manabe, Yoshihiko, et al.
Publicado: (2020)

Percutaneous fiducial marker placement prior to stereotactic body radiotherapy for malignant liver tumors: an initial experience
por: Ohta, Kengo, et al.
Publicado: (2016)

Radiotherapy for a rare phosphaturic mesenchymal tumor in the middle ear presenting with oncogenic osteomalacia: A case report
por: Takaoka, Taiki, et al.
Publicado: (2021)

Percutaneous fiducial marker placement under CT fluoroscopic guidance for stereotactic body radiotherapy of the lung: an initial experience
por: Ohta, Kengo, et al.
Publicado: (2013)

Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience
por: Iwabuchi, Michio, et al.
Publicado: (2016)

Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results
por: Baba, Fumiya, et al.
Publicado: (2009)

Stereotactic body radiotherapy using a hydrogel spacer for localized prostate cancer: A dosimetric comparison between tomotherapy with the newly‐developed tumor‐tracking system and cyberknife
por: Manabe, Yoshihiko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0v6o2jcbi7uhd0epuhns4afoa8